VISULUX

K161607 · Carl Zeiss Meditec, AG · HJO · Feb 23, 2017 · Ophthalmic

Device Facts

• Record ID: K161607
• Device Name: VISULUX
• Applicant: Carl Zeiss Meditec, AG
• Product Code: HJO · Ophthalmic
• Decision Date: Feb 23, 2017
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 886.1850
• Device Class: Class 2

Intended Use

The fiber slit illuminator is indicated for use as an alternative illumination system to the surgical microscope in ophthalmic microsurgery for procedures on the anterior and posterior segments of the eye. The fiber slit illuminator is not equipped with a light source, but uses the light transferred from the microscope by a light guide.

Device Story

VISULUX is a fiber slit illuminator attachment for surgical microscopes used by ophthalmologists during microsurgery. It lacks an internal light source; it receives light from the host microscope via a light guide. The device channels light through an optical system to project a bright, sharp, adjustable slit beam onto the eye, enhancing contrast for observation. It is designed for use in clinical surgical settings. The operator adjusts the slit width using a slideable aperture. By providing high-contrast illumination, it assists the surgeon in visualizing ocular structures, facilitating precise surgical decision-making and improving procedural outcomes.

Clinical Evidence

No clinical data or animal studies were conducted. Substantial equivalence is supported by bench testing, including compliance with ANSI/AAMI ES60601-1 (safety), IEC 60601-1-2 (EMC), ISO 10939 (ophthalmic instruments), and ISO 15004-2 (light hazard protection).

Technological Characteristics

Fiber slit illuminator attachment. Passive optical device; no internal light source. Connects to surgical microscopes (e.g., OPMI Lumera/VISU series) via light guide. Features a slideable aperture for beam width adjustment. Complies with ISO 10939 and ISO 15004-2 for light hazard protection. No software.

Indications for Use

Indicated for ophthalmic microsurgery procedures on the anterior and posterior segments of the eye. No specific age or gender restrictions provided.

Regulatory Classification

Identification

An AC-powered slitlamp biomicroscope is an AC-powered device that is a microscope intended for use in eye examination that projects into a patient's eye through a control diaphragm a thin, intense beam of light.

Special Controls

*Classification.* Class II (special controls). The device, when it is intended only for the visual examination of the anterior segment of the eye, is classified as Group 1 per FDA-recognized consensus standard ANSI Z80.36, does not provide any quantitative output, and is not intended for screening or automated diagnostic indications, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.

Predicate Devices

• SL 115 Classic slit lamp (K133476)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of an eagle or bird with three overlapping profiles facing to the right. The profiles are rendered in a dark color, creating a sense of depth and unity. Encircling the bird is the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

February 23, 2017

Carl Zeiss Meditec AG Dr. Christian Muenster Director Clinical & Regulatory Affairs Rudolf-Eber-Strasse 11 73447 Oberkochen, Germany

Re: K161607

Trade/Device Name: Visulux Regulation Number: 21 CFR 886.1850 Regulation Name: AC-Powered Slitlamp Biomicroscope Regulatory Class: Class II Product Code: HJO Dated: December 21, 2016 Received: January 12, 2017

Dear Dr. Muenster:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Image /page/1/Picture/7 description: The image shows the name "Denise L. Hampton -S" in a large, bold font. The name is written in black and is centered on the image. The background of the image is white. The text is clear and easy to read.

for Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

### Indications for Use

510(k) Number (if known) K161607

Device Name VISULUX

Indications for Use (Describe)

The fiber slit illuminator is indicated for use as an alternative illumination system to the surgical microscope in ophthalmic microsurgery for procedures on the anterior segments of the eye. The fiber slit illuminator is not equipped with a light source, but uses the light transferred from the microscope by a light guide.

| Type of Use (Select one or both, as applicable) | |
|----------------------------------------------------------------------------|---------------------------------------------------------------------------|
| <span> Prescription Use (Part 21 CFR 801 Subpart D) </span> | <span> Over-The-Counter Use (21 CFR 801 Subpart C) </span> |

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

***DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.***

The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services

Food and Drug Administration

Office of Chief Information Officer

Paperwork Reduction Act (PRA) Staff [e-mail] "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

Form Approved: OMB No. 0910-0120

Expiration Date: January 31, 2017

See PRA Statement below.

{3}------------------------------------------------

## 510(K) SUMMARY

## 510(k) SUMMARY (as per 21 CFR §807.92)

# VISULUX

# GENERAL INFORMATION

| Manufacturer: | Carl Zeiss Meditec AG<br>Goeschwitzer Strasse 51-52<br>07745 Jena, Germany<br>[phone] (phone)<br>[phone] (fax)<br>Establishment Registration Number: 9615030 |
|-------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Christian Muenster<br>Director Clinical and Regulatory Affairs<br>Carl Zeiss Meditec AG<br>Rudolf-Eber-Strasse 11<br>73447 Oberkochen, Germany<br>[phone] Phone<br>[phone] Fax<br>E-mail: [e-mail] |
| Date prepared: | February 22, 2017 |
| Classification Name: | Biomicroscope, Slit-lamp, AC-powered |
| Product Code and Class: | HJO - Class 2 |
| Classification: | 21 CFR 886.1850 |
| Trade/Proprietary Name: | VISULUX |
| Predicate Device | SL 115 Classic slit lamp<br>Manufactured by Carl Zeiss Meditec |
| Predicate 510(k) Number | K133476 |

{4}------------------------------------------------

## DEVICE DESCRIPTION (21 CFR §807.92(a)(4))

The VISULUX is intended to be used together with a microscope to perform ophthalmic observations. The device is primarily used by surgical ophthalmologists. As the device has no own light source the microscope must provide an additional separate light source or at least a separate S-light guide to be connected to the VISULUX.

The released devices for mounting the VISULUX are as followed:

- OPMI Lumera 700 .
- . OPMI Lumera T on S8, S81 or S88 stand
- . OPMI VISU 210 on S8. S81 or S88 stand
- OPMI VISU 200 (Brightflex) on S8, S81 or S88 stands .
- OPMI VISU 160 on S8, S81 or S88 stands
- . OPMI VISU 150 (Brightflex) on S8, S81 or S88 stands

All these devices are Class I devices and are listed under the establishment number 9615010 (Carl Zeiss Meditec AG), regulation number 878.4700.

All microscopes consist of the microscope itself and a floor stand or a ceiling mount. As a rule the light sources are integrated in the floor stand or ceiling mount. This light source is also used to feed the VISULUX.

Regarding the OPMI Lumera 700 the floor stand and ceiling mount is not named separately as it is designed especially for the OPMI Lumera 700. Also here the importing item is the floor stand as in here the light source is integrated. OPMI Lumera 700 is a product consisting of microscope and stand. Based on this the stand is not listed or named separately.

The light is brought by a light guide in the device and is channeled through an optical system to leave the device as a bright, sharp slit. The operator can adjust the beam with a slideable aperture to have different widths.

### INDICATIONS FOR USE (21 CFR §807.92(a)(5))

The fiber slit illuminator is indicated for use as an alternative illumination system to the surgical microscope in ophthalmic microsurgery for procedures on the anterior and posterior segments of the eye. The fiber slit illuminator is not equipped with a light source, but uses the light transferred from the microscope by a light guide.

{5}------------------------------------------------

### RISK MANAGEMENT

The device labeling contains instructions for use and any necessary cautions and warnings to provide for safe and effective use of the device. VISULUX has an own Instruction for Use.

Risk management is ensured via a risk analysis, which is used to identify potential hazards and mitigations. These potential hazards are controlled by design means, protection measures and user instructions. To confirm that the measures are effective and that the product meets its intended uses, verification of requirements and standards, and validation of the clinical workflow was performed. Carl Zeiss Meditec adheres to recognized and established industry practice and relevant international standards where indicated.

### TECHNOLOGICAL CHARACTERISTICS AND SUBSTANTIAL EQUIVALENCE (21 CFR §807.92(a) (6)):

VISULUX is substantially equivalent in intended use, mechanism of action and principle of operation to the cleared device from Carl Zeiss Meditec, SL 115 Classic slit lamp (K133476). This predicate has not been subject to a design-related recall.

Each system produce a bright, sharply delimited slit image for high-contrast observation through the surgical microscope. VISULUX itself has no surgical microscope but uses the device where it is attached to.

The predicate is a stand-alone slit lamp including a surgical microscope.

VISULUX has no own light source. The microscope where the VISULUX is attached to must provide a separate light source and a separate S light guide to be connected to.

The predicate has its own light source.

Evaluation performed on the VISULUX supports the indications for use statement and demonstrates that the device is substantially equivalent to the predicate device and does not raise new questions regarding safety and effectiveness.

{6}------------------------------------------------

## SUMMARY OF PERFORMANCE DATA (21 CFR §807.92(B))

The following performance data were provided in support of the substantial equivalence determination.

- ISO 14971:2007 is a general standard with no specific test acceptance criteria. This standard was used to demonstrate compliance with risk management processes and to support ANSI/AAMI ES60601-1 and IEC 60601-1-2.
### ● ANSI/AAMI ES60601-1:2005/(R)2012 and A1:2012, C1:2009/(R)2012 and A2:2010/(R)2012

Basic safety and essential performance has been evaluated for the VISULUX. VISULUX has been found to be in compliance with the ANSI/AAMI ES60601-1:2005/(R) 2012 and A1:2012, C1:2009/(R) 2012 and A2:2010/(R) 2012 standard.

### IEC 60601-1-2:2007 ●

Electromagnetic compatibility (EMC) has been evaluated for VISULUX. VISULUX has been found to be in compliance with the IEC 60601-1-2:2007 standard.

### ISO 10939:2007 .

The ISO 10939, applicable for ophthalmic instruments and in particular Slit-lamp microscopes has been evaluated for the VISULUX. It was made in conjunction with all applicable light sources (LED, Halogen and Xenon). The VISULUX has been found to be in compliance with the ISO 10939 standard.

### ISO 15004-2:2007 ●

The ISO 15004-2, describing Fundamental requirements and test methods for Light hazard protection has been evaluated for the VISULUX. The device has been found to be in compliance with ISO 15004-2 standard.

### ● IEC 62366-1:2015

IEC 62366-1:2015, Medical devices - Application of usability engineering to medical devices is a general standard with no specific test acceptance criteria. This standard was used to demonstrate compliance to human factors engineering processes, commonly known as "Usability Engineering" applicable to the product design and development process.

### Software Verification and Validation Testing ●

VISULUX does not contain software

### ● Animal Study

Animal Studies were not conducted for this device as it is not needed to support substantial equivalence to the predicate devices.

{7}------------------------------------------------

- Clinical Studies
Clinical Studies were not conducted for this device as it is not needed to support substantial equivalence to the predicate devices.

## Conclusion

The non-clinical data support the safety of the device and the hardware verification and validation demonstrate that the VISULUX should perform as intended in the specified use conditions.

The data demonstrate that the VISULUX performs comparably to the predicate device that is currently marketed for the same intended use.

## SUBSTANTIAL EQUIVALENCE TO PREDICATE (21 CFR §807.92(B)(1):

As previously indicated VISULUX has been tested to meet the product requirements (PRS) and is considered to be substantially equivalent to the predicate as indicated above.

## 510(K) SUMMARY (21 CFR \$807.92(C)):

In summary, based on the successful verification and validation testing, it is Carl Zeiss Meditec AG's opinion that VISULUX does not introduce any new potential safety risks and is substantially equivalent to, and performs as well as, the predicate device.

Additionally, all testing deemed necessary was conducted on VISULUX to ensure that the device is as safe and effective when used in accordance with its Instructions for Use as the predicate device.